STOCK TITAN

[Form 4] SI-BONE, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

John G. Freund, a director of SI-BONE, Inc. (SIBN), reported insider sales and remaining holdings. The Form 4 shows a sale (Code S) of 12,132 shares on 08/08/2025 at a weighted-average price of $15.9906, executed in multiple trades with prices ranging from $15.80 to $16.3950. The filing also records a reported disposition of 43,301 shares which includes 8,675 restricted stock units.

The report shows 91,767 shares beneficially owned following the reported transaction(s), held indirectly by John Freund Family Partnership IV, L.P. The filing notes the Reporting Person is a general partner of that Family LP and disclaims beneficial ownership except to the extent of pecuniary interest.

John G. Freund, direttore di SI-BONE, Inc. (SIBN), ha segnalato vendite da insider e le partecipazioni residue. Il Modulo 4 mostra una vendita (Codice S) di 12,132 azioni il 08/08/2025 a un prezzo medio ponderato di $15.9906, eseguita in più operazioni con prezzi compresi tra $15.80 e $16.3950. La comunicazione registra inoltre una cessione segnalata di 43,301 azioni che include 8,675 unità di azioni soggette a restrizioni.

Il rapporto mostra 91,767 azioni detenute a titolo beneficiario dopo la/le transazione/i segnalata/e, detenute indirettamente da John Freund Family Partnership IV, L.P. La comunicazione precisa che la persona che effettua la segnalazione è general partner di tale Family LP e disconosce la proprietà beneficiaria, salvo nella misura dell'interesse pecuniario.

John G. Freund, director de SI-BONE, Inc. (SIBN), informó ventas de insider y las participaciones restantes. El Formulario 4 muestra una venta (Código S) de 12,132 acciones el 08/08/2025 a un precio medio ponderado de $15.9906, ejecutada en varias operaciones con precios que oscilan entre $15.80 y $16.3950. La presentación también registra una disposición informada de 43,301 acciones que incluye 8,675 unidades de acciones restringidas.

El informe indica que tras la(s) transacción(es) reportada(s) se poseen beneficiariamente 91,767 acciones, mantenidas de forma indirecta por John Freund Family Partnership IV, L.P. La presentación señala que la persona informante es socia general de esa Family LP y renuncia a la propiedad beneficiaria salvo en la medida de su interés pecuniario.

SI-BONE, Inc. (SIBN)의 이사 John G. Freund가 내부자 매도 및 잔여 보유를 신고했습니다. Form 4에는 12,132주의 매도(코드 S)가 08/08/2025에 가중평균가격 $15.9906으로 보고되어 있으며, 여러 거래로 실행되어 가격은 $15.80에서 $16.3950 사이였습니다. 제출서류는 또한 8,675개의 제한 주식 단위를 포함한 43,301주의 처분 보고를 기록하고 있습니다.

보고서에 따르면 보고된 거래 후 91,767주를 실질적으로 보유하고 있으며 이는 John Freund Family Partnership IV, L.P.를 통해 간접적으로 보유됩니다. 신고서에는 보고인이 해당 패밀리 LP의 제너럴 파트너임을 밝히고, 금전적 이익의 범위 내를 제외하고는 실질적 소유권을 부인한다고 기재되어 있습니다.

John G. Freund, administrateur de SI-BONE, Inc. (SIBN), a déclaré des ventes d'initié et les participations restantes. Le formulaire 4 indique une vente (Code S) de 12,132 actions le 08/08/2025 à un prix moyen pondéré de $15.9906, exécutée en plusieurs opérations avec des prix allant de $15.80 à $16.3950. Le dépôt enregistre également une cession signalée de 43,301 actions qui comprend 8,675 unités d'actions restreintes.

Le rapport indique que 91,767 actions sont détenues à titre bénéficiaire après la ou les transactions rapportées, détenues indirectement par John Freund Family Partnership IV, L.P. Le dépôt précise que la personne déclarante est un associé commandité de cette Family LP et décline la propriété bénéficiaire, sauf dans la mesure de son intérêt pécuniaire.

John G. Freund, Direktor von SI-BONE, Inc. (SIBN), meldete Insiderverkäufe und verbleibende Beteiligungen. Das Formular 4 zeigt einen Verkauf (Code S) von 12,132 Aktien am 08/08/2025 zu einem gewichteten Durchschnittspreis von $15.9906, ausgeführt in mehreren Transaktionen mit Preisen zwischen $15.80 und $16.3950. Die Einreichung verzeichnet außerdem eine gemeldete Veräußerung von 43,301 Aktien, die 8,675 Restricted Stock Units (RSUs) einschließt.

Der Bericht zeigt, dass nach den gemeldeten Transaktionen 91,767 Aktien wirtschaftlich gehalten werden, und zwar indirekt durch John Freund Family Partnership IV, L.P. Die Einreichung weist darauf hin, dass die meldende Person General Partner dieser Family LP ist und wirtschaftliches Eigentum nur insoweit geltend macht, wie es ihrem pecuniären Interesse entspricht.

Positive
  • Retains substantial indirect stake: 91,767 shares held by John Freund Family Partnership IV, L.P.
  • Clear disclosure: Form 4 provides weighted-average sale price and the trade price range ($15.80 to $16.3950).
Negative
  • Insider sale: 12,132 shares sold at a weighted-average price of $15.9906 on 08/08/2025.
  • Disposition includes RSUs: 43,301 shares reported disposed includes 8,675 restricted stock units, affecting future share issuance/settlement.

Insights

TL;DR: Insider sale of 12,132 shares at ~$16; significant indirect stake remains (91,767), so market impact likely limited absent other disclosures.

The Form 4 documents a clear, executed sale of 12,132 common shares at a weighted-average of $15.9906, with individual trade prices between $15.80 and $16.3950. The filing preserves material context by showing 91,767 shares held indirectly by John Freund Family Partnership IV, L.P., indicating continued economic exposure. The report also flags a separate reported disposition of 43,301 shares that includes 8,675 restricted stock units, which affects potential future share availability.

TL;DR: Transaction disclosed transparently; indirect ownership via a family partnership remains substantial, and RSU inclusion clarifies compensation-related shares.

The disclosure follows Section 16 requirements, providing weighted-average sale price and trade range. Notably, the reporting person is identified as general partner of the Family LP that holds 91,767 shares, and the filing expressly disclaims beneficial ownership aside from pecuniary interest. The note that 8,675 restricted stock units are included in the 43,301 reported shares helps separate compensation-driven share movements from discretionary open-market trades.

John G. Freund, direttore di SI-BONE, Inc. (SIBN), ha segnalato vendite da insider e le partecipazioni residue. Il Modulo 4 mostra una vendita (Codice S) di 12,132 azioni il 08/08/2025 a un prezzo medio ponderato di $15.9906, eseguita in più operazioni con prezzi compresi tra $15.80 e $16.3950. La comunicazione registra inoltre una cessione segnalata di 43,301 azioni che include 8,675 unità di azioni soggette a restrizioni.

Il rapporto mostra 91,767 azioni detenute a titolo beneficiario dopo la/le transazione/i segnalata/e, detenute indirettamente da John Freund Family Partnership IV, L.P. La comunicazione precisa che la persona che effettua la segnalazione è general partner di tale Family LP e disconosce la proprietà beneficiaria, salvo nella misura dell'interesse pecuniario.

John G. Freund, director de SI-BONE, Inc. (SIBN), informó ventas de insider y las participaciones restantes. El Formulario 4 muestra una venta (Código S) de 12,132 acciones el 08/08/2025 a un precio medio ponderado de $15.9906, ejecutada en varias operaciones con precios que oscilan entre $15.80 y $16.3950. La presentación también registra una disposición informada de 43,301 acciones que incluye 8,675 unidades de acciones restringidas.

El informe indica que tras la(s) transacción(es) reportada(s) se poseen beneficiariamente 91,767 acciones, mantenidas de forma indirecta por John Freund Family Partnership IV, L.P. La presentación señala que la persona informante es socia general de esa Family LP y renuncia a la propiedad beneficiaria salvo en la medida de su interés pecuniario.

SI-BONE, Inc. (SIBN)의 이사 John G. Freund가 내부자 매도 및 잔여 보유를 신고했습니다. Form 4에는 12,132주의 매도(코드 S)가 08/08/2025에 가중평균가격 $15.9906으로 보고되어 있으며, 여러 거래로 실행되어 가격은 $15.80에서 $16.3950 사이였습니다. 제출서류는 또한 8,675개의 제한 주식 단위를 포함한 43,301주의 처분 보고를 기록하고 있습니다.

보고서에 따르면 보고된 거래 후 91,767주를 실질적으로 보유하고 있으며 이는 John Freund Family Partnership IV, L.P.를 통해 간접적으로 보유됩니다. 신고서에는 보고인이 해당 패밀리 LP의 제너럴 파트너임을 밝히고, 금전적 이익의 범위 내를 제외하고는 실질적 소유권을 부인한다고 기재되어 있습니다.

John G. Freund, administrateur de SI-BONE, Inc. (SIBN), a déclaré des ventes d'initié et les participations restantes. Le formulaire 4 indique une vente (Code S) de 12,132 actions le 08/08/2025 à un prix moyen pondéré de $15.9906, exécutée en plusieurs opérations avec des prix allant de $15.80 à $16.3950. Le dépôt enregistre également une cession signalée de 43,301 actions qui comprend 8,675 unités d'actions restreintes.

Le rapport indique que 91,767 actions sont détenues à titre bénéficiaire après la ou les transactions rapportées, détenues indirectement par John Freund Family Partnership IV, L.P. Le dépôt précise que la personne déclarante est un associé commandité de cette Family LP et décline la propriété bénéficiaire, sauf dans la mesure de son intérêt pécuniaire.

John G. Freund, Direktor von SI-BONE, Inc. (SIBN), meldete Insiderverkäufe und verbleibende Beteiligungen. Das Formular 4 zeigt einen Verkauf (Code S) von 12,132 Aktien am 08/08/2025 zu einem gewichteten Durchschnittspreis von $15.9906, ausgeführt in mehreren Transaktionen mit Preisen zwischen $15.80 und $16.3950. Die Einreichung verzeichnet außerdem eine gemeldete Veräußerung von 43,301 Aktien, die 8,675 Restricted Stock Units (RSUs) einschließt.

Der Bericht zeigt, dass nach den gemeldeten Transaktionen 91,767 Aktien wirtschaftlich gehalten werden, und zwar indirekt durch John Freund Family Partnership IV, L.P. Die Einreichung weist darauf hin, dass die meldende Person General Partner dieser Family LP ist und wirtschaftliches Eigentum nur insoweit geltend macht, wie es ihrem pecuniären Interesse entspricht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Freund John Gordon

(Last) (First) (Middle)
C/O SKYLINE VENTURES
525 UNIVERSITY AVENUE, SUITE 1350

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 S 12,132 D $15.9906(1) 91,767 I By John Freund Family Partnership IV, L.P(2)
Common Stock 43,301(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $15.80 USD to $16.3950 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. Shares held by John Freund Family Partnership IV, L.P. ("Family LP"). Reporting Person, a member of Issuer's board of directors, is a general partner of Family LP and may be deemed to have voting and investment power with respect to the securities held by Family LP. Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
3. Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Remarks:
/s/ Michael A. Pisetsky, Attorney-in-Fact for John G. Freund 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SI-BONE (SIBN) director John G. Freund report on Form 4?

The Form 4 reports a sale of 12,132 shares on 08/08/2025 at a weighted-average price of $15.9906, a reported disposition of 43,301 shares (including 8,675 RSUs), and 91,767 shares beneficially owned indirectly by John Freund Family Partnership IV, L.P.

How many shares were sold and at what price?

The filing shows 12,132 shares sold at a weighted-average price of $15.9906; individual trades ranged from $15.80 to $16.3950.

What is John Freund's ownership after the reported transaction(s)?

The Form 4 indicates 91,767 shares beneficially owned following the reported transactions, held indirectly by John Freund Family Partnership IV, L.P.

Does the filing mention restricted stock units (RSUs)?

Yes. The filing states that the 43,301 shares reported include 8,675 shares issuable upon settlement of restricted stock units granted to the Reporting Person.

What is the reporting person’s relationship to SI-BONE?

The reporting person, John G. Freund, is identified as a Director and is a general partner of John Freund Family Partnership IV, L.P., which holds the indirect shares.
Si-Bone

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Latest SEC Filings

SIBN Stock Data

677.31M
38.38M
3.07%
97.16%
4.41%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA